Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
! Fred!Cohen,!M.D.,!D.Phil.,!Partner!and!Managing!Director! Prior! to! joining! TPG! Biotech! in! 2001,! Fred! was! a! Professor! of! medicine,! cellular! and! molecular! pharmacology,! biochemistry! and! biophysics,! and! pharmaceutical! chemistry! at! UCSF.! In! this! context,! he! was! Chief! of! the! Division! of! Endocrinology! and! Metabolism! and! directed! an! active! research!program!in!the!areas!of!prion!biology,!structure!based!drug!design,!bioinformatics!and! heteropolymer! chemistry.! Fred! is! a! Fellow! of! the! National! Academy! of! Medicine! (formerly! the! IOM),!the!American!Academy!of!Arts!and!Sciences,!and!the!American!College!of!Physicians.!He!is! ! a! member! of! the! American! Society! for! Clinical! Investigation! and! the! Association! of! American! Physicians,! and! the! recipient! of! several! awards! and! honors! including! the! BurroughsPWellcome! New! Initiatives! in! Malaria! Award,! the! LVMH! Science! Pour! L’Art! Prize! (shared! with! Stanley! Prusiner),! a! Searle! Scholars! Award,! and! Young! Investigator! Awards! from! the! Endocrine! Society! and! the! Western! Society! for! Clinical! Investigation.! He! graduated! Magna! Cum! Laude! from! Yale! University!in!1978!and!received!his!D.Phil!from!Oxford!University!as!a!Rhodes!Scholar!in!1980,!his! M.D.!from!Stanford!Medical!School!as!an!American!Cancer!Society!Postdoctoral!Fellow!in!1984,! and!his!internal!medicine!and!endocrinology!training!at!UCSF.!He!joined!TPG!in!2001!to!initiate! TPG’s! venture! efforts! in! biotechnology! and! life! sciences.! He! currently! serves! on! the! Board! of! Directors! of:! BioCryst! (BCRX),! CareDx! (! CDNA),! Five! Prime! Therapeutics! (FPRX),! Genomic! Health! (GHDX),!Progyny,!Rapid!Micro!Biosystems,!Roka!Bioscience(ROKA),!Tandem(TNDM),!and!Veracyte! (VCYT).! Heath!Lukatch,!Ph.D.,!Partner!and!Managing!Director! Prior! to! joining! TPG! Biotech! in! 2015,! Heath! was! a! Partner! at! Novo! Ventures! (US),! where! he! helped!establish!Novo!Ventures’!San!Francisco!office.!During!his!9!years!at!Novo,!Heath!served!as! Chairman! of! Cianna! Medical,! Inogen! (INGN),! NTP,! and! Spinifex! Pharmaceuticals! (acquired! by! Novartis!in!2015).!He!served!as!a!board!member!at!Amira!Pharmaceuticals!(acquired!by!BMS!in! 2011),! AnaptysBio,! Elevation! Pharmaceuticals! (acquired! by! Sunovion! in! 2012),! Flexion! Therapeutics! (FLXN),! FoldRx! Pharmaceuticals! (acquired! by! Pfizer! in! 2010),! InSound! Medical! (acquired!by!Sonova!in!2010),!Nora!Therapeutics,!and!Synosia!Therapeutics!(acquired!by!BioTie!in! 2011),! and! was! a! board! observer! at! Alios! BioPharma! (acquired! by! J&J! in! 2014).! Prior! to! joining! Novo,!Dr.!Lukatch!was!a!Managing!Director!responsible!for!biotechnology!venture!investments!at! Piper! Jaffray! Ventures! and! SightLine! Partners,! where! his! investments! included! Dynavax! (DVAX)! and! Fluidigm! (FLDM).! Before! Piper! Jaffray! Ventures,! he! worked! as! a! strategy! consultant! with! McKinsey!&!Company,!where!he!was!a!leader!in!McKinsey’s!biotechnology!practice.!Heath!also! served!as!CoPfounder!and!CEO!of!AutoMate!Scientific,!a!biotechnology!instrumentation!company,! and! he! has! held! scientific! positions! with! Chiron,! Roche! Bioscience,! and! Cetus,! doing! molecular! biology,! electrophysiology! and! protein! chemistry,! respectively.! Heath! received! his! Ph.D.! in! neuroscience!from!Stanford!University,!where!he!was!a!DOD!USAF!Fellow,!and!his!B.A.!with!High! Honors!in!Biochemistry!from!the!University!of!California!at!Berkeley.! ! Eran!Nadav,!Ph.D.,!Partner!and!Managing!Director! ! Eran! joined! TPG! Biotech! in! 2007! to! invest! in! global! pharmaceuticals! and! biotechnology.! He! invests! in! a! broad! range! of! earlyP! to! latePstage! companies! and! products,! including! innovative! therapies!and!high!value!generics.!Prior!to!TPG,!Eran!served!as!Business!Development!Director!at! Eisai,!where!he!evaluated!and!negotiated!notable!licensing!and!acquisition!deals.!Prior!to!this!he! worked!for!the!Israeli!office!of!JJDC,!the!venture!capital!subsidiary!of!Johnson!&!Johnson,!where! he! analyzed! and! executed! investments! in! innovative! technologies! and! biopharmaceuticals.! Previously,! Dr.! Nadav! worked! for! Neurim! Pharmaceuticals! Ltd.! supporting! the! clinical! development! of! Circadin®.! He! holds! a! Ph.D.! in! biochemistry,! M.Sc.!Magna! Cum! Laude,! B.Sc.!Magna! Cum! Laude,! and! MBA! P! all! from! Tel! Aviv! University.! Eran! currently! serves! as! Chairman! of! the! Board! of! Trevi! Therapeutics,! and! Board! member! at! Collegium! Pharmaceutical! (COLL),!ShangPharma!(a!ChinaPbased!CRO),!and!NovaSom.!He!was!the!Chairman!of!the!Board!of! Ultragenyx!Pharmaceutical!(RARE)!from!January!2012!to!June!2015.!Other!past!investments!and! Board! roles! include! JCR! Pharmaceuticals! (a! Japanese! biopharma! company;! 4552),! MacroGenics! (MGNX),!and!Mayanot!Eden.! ! ! ! ! Heather!Preston,!M.D.,!Partner!and!Managing!Director! Prior! to! joining! TPG! Biotech! in! 2005,! Dr.! Preston! spent! two! years! at! JP! Morgan! Partners! where! she! focused! on! medical! device! and! biotechnology! venture! capital! investing.! Prior! to! JP! Morgan! Partners,!Dr.!Preston!was!an!EntrepreneurPinPResidence!with!New!Enterprise!Associates.!She!also! spent!five!years!at!McKinsey!&!Co.!in!New!York,!where!she!was!a!leader!of!their!pharmaceutical! and!medical!products!consulting!practice.!Heather!advised!large!pharmaceutical!companies!and! biotechnology! companies! on! critical! strategic! issues! such! as! R&D! portfolio! prioritization,! M&A! opportunities,! new! technology! acquisitions,! new! product! launches,! and! product! growth! strategies.! Dr.! Preston! has! an! undergraduate! degree! in! biochemistry! from! the! University! of! London!and!a!medical!degree!from!the!University!of!Oxford.!Heather!completed!a!postPdoctoral! fellowship! in! molecular! biology! at! the! Dana! Farber! Cancer! Institute,! Harvard! University,! and! trained! in! Internal! Medicine! at! the! Massachusetts! General! Hospital! and! subPspecialized! in! Gastroenterology! and! Hepatology! at! UCSF.! During! her! academic! medical! career,! she! was! the! recipient! of! a! Fulbright! Scholarship,! a! Fulbright! Cancer! Research! Scholarship,! a! Harlech! Scholarship! and! a! Science! and! Engineering! Research! Council! PostPdoctoral! Fellowship! Award.! Heather!currently!serves!on!the!Board!of!Directors!of!Albireo,!Alder!BioPharmaceuticals!(ALDR),! Enlibrium,!Otonomy!(OTIC),!Unchained!Labs,!and!Virobay.!She!previously!served!on!the!Boards!of! Aptalis!Pharma!(acquired!by!Forest!Labs!in!February!2014),!Conventus,!Elevation!Pharmaceuticals! (acquired!by!Sunovion!in!September!2012),!Vibrynt,!VLST,!and!is!responsible!for!overseeing!TPG! Biotech's!investment!in!Par!Pharmaceuticals.!Heather!also!serves!on!the!Board!of!Trustees!for!the! Fine!Arts!Museums!of!San!Francisco,!Saint!Luke's!School!and!the!Harlech!Scholarship!Foundation.! ! Cayce!Denton,!Vice!President! ! Prior! to! joining! TPG! Biotech! in! 2010,! Cayce! managed! finance! for! the! Nutropin! and! Lytics! franchises! at! Genentech,! where! she! also! participated! in! a! CFO! Rotation! Program! consisting! of! time! in! R&D! Finance,! Financial! Planning! and! Analysis,! Audit,! and! Treasury.! Prior! to! Genentech,! she! was! in! Business! Development! at! Novartis! in! Cambridge,! where! she! helped! execute! an! approximately! $700! million! partnership! with! Alnylam! Pharmaceuticals.! Prior! to! Novartis,! Cayce!! worked! in! biotech! venture! capital! at! Atlas! Venture! and! was! an! investment! banker! with! Credit! Suisse! First! Boston’s! Technology! Group,! in! Boston.! Ms.! Denton! has! an! MBA! from! the! Wharton! School!of!the!University!of!Pennsylvania,!where!she!was!awarded!the!F.!H.!Shields!Fellowship!and! coPfounded! the! Biotech! Investment! Group,! and! a! B.S.! from! M.I.T.! in! Biology.! Ms.! Denton! is! a! board!member!of!PatientSafe!Solutions!and!Trevi!Therapeutics.! ! Peter!Bojo,!Associate! Prior!to!joining!TPG!Biotech!in!2014,!Peter!worked!in!management!consulting!at!Oliver!Wyman! for! 3! years! with! projects! including! strategy! and! M&A! engagements! within! healthcare! and! financial! services.! Prior! to! Oliver! Wyman,! he! worked! in! R&D! at! a! medical! device! startup.! Peter! has!a!Master’s!and!a!B.S.!from!M.I.T.!in!Bioengineering,!has!coPauthored!several!papers,!and!is!a! member!of!Tau!Beta!Pi!and!Phi!Beta!Kappa!honor!societies.! ! !